ReNewVax Ltd.
PrivateLast Round
Series A
Nov 6, 2025
Total Funding Raised
$3.3M
Company Overview
ReNewVax Ltd. is a biotechnology company that develops novel protein-based vaccines targeting bacterial infections and antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReNewVax Ltd. Comparables
Compare ReNewVax Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GPN Vaccines | 83% | |
| Inventprise | 77% | |
| i-Seq Biotechnology | 75% | |
ReNewVax Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 6, 2025 | ||||
| Seed | Aug 8, 2025 |
ReNewVax Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QUBIS | Seed |
| Innovate UK | Seed |
| LYVA Labs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Monthly visitors increased 316% MoM.
ReNewVax Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ReNewVax Ltd.'s valuation, stock price, and market status.